296 related articles for article (PubMed ID: 36569844)
21. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
[TBL] [Abstract][Full Text] [Related]
23. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
24. A novel prognostic model based on multi-omics features predicts the prognosis of colon cancer patients.
Yang H; Jin W; Liu H; Wang X; Wu J; Gan D; Cui C; Han Y; Han C; Wang Z
Mol Genet Genomic Med; 2020 Jul; 8(7):e1255. PubMed ID: 32396280
[TBL] [Abstract][Full Text] [Related]
25. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
26. A prognostic prediction model for ovarian cancer using a cross-modal view correlation discovery network.
Wang H; Han X; Ren J; Cheng H; Li H; Li Y; Li X
Math Biosci Eng; 2024 Jan; 21(1):736-764. PubMed ID: 38303441
[TBL] [Abstract][Full Text] [Related]
27. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
28. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
[TBL] [Abstract][Full Text] [Related]
29. Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis.
Zhang Z; Wei Z; Zhao L; Gu C; Meng Y
J Obstet Gynaecol; 2023 Dec; 43(1):2171778. PubMed ID: 36803381
[TBL] [Abstract][Full Text] [Related]
30. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.
Dayde D; Tanaka I; Jain R; Tai MC; Taguchi A
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272347
[TBL] [Abstract][Full Text] [Related]
31. Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer.
Ji D; Zhang D; Zhan T; Jia J; Han W; Li Z; Li M; Song C; Wang J; Gu J
Genomics; 2021 Jan; 113(1 Pt 2):957-966. PubMed ID: 33129922
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary.
Bochtler T; Wohlfromm T; Hielscher T; Stichel D; Pouyiourou M; Kraft B; Neumann O; Endris V; von Deimling A; Stenzinger A; Krämer A
Genes Chromosomes Cancer; 2022 Sep; 61(9):551-560. PubMed ID: 35430765
[TBL] [Abstract][Full Text] [Related]
33. Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer.
Zhou Y; Xu Y; Wang C; Gong Y; Zhang Y; Yao R; Li P; Zhu X; Bai J; Guan Y; Xia X; Yang L; Yi X; Sun Q
Breast Cancer Res Treat; 2021 Aug; 188(3):661-673. PubMed ID: 34003409
[TBL] [Abstract][Full Text] [Related]
34. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
Front Immunol; 2022; 13():994828. PubMed ID: 36405728
[TBL] [Abstract][Full Text] [Related]
35. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
36. Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions.
Kubota S; Miura T; Wakiya T; Yoshizawa T; Goto S; Morohashi H; Sakamoto Y; Tatara Y; Kijima H; Hakamada K
Ann Surg Oncol; 2023 Nov; 30(12):7612-7623. PubMed ID: 37548833
[TBL] [Abstract][Full Text] [Related]
37. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
38. A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.
Li J; Tong Y; Wang Z; Liu Y; Dai X; Zhu Y
J Oncol; 2021; 2021():7404927. PubMed ID: 34539785
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Bengala C; Bettelli S; Bertolini F; Sartori G; Fontana A; Malavasi N; Depenni R; Zironi S; Del Giovane C; Luppi G; Conte PF
Br J Cancer; 2010 Sep; 103(7):1019-24. PubMed ID: 20842128
[TBL] [Abstract][Full Text] [Related]
40. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
